Pieris Pharmaceu Stock Price, News & Analysis
Company Description
Pieris Pharmaceu (NASDAQ: PIRS) is a publicly traded research and development in biotechnology company in the Pharmaceutical Preparations sector. The company has a market capitalization of $18.0M, ranking #6,182 among all listed U.S. companies by market cap.
PIRS stock has gained 21.4% over the past year. Shares last traded at $13.60.
This page provides a comprehensive overview of PIRS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Pieris Pharmaceu (PIRS) stock last traded at $13.60. Over the past 12 months, the stock has gained 21.4%. At a market capitalization of $18.0M, PIRS is classified as a micro-cap stock with approximately 1.3M shares outstanding.
Latest News
Pieris Pharmaceu has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, stock split, clinical trial, conferences, earnings. View all PIRS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
PIRS Company Profile & Sector Positioning
Pieris Pharmaceu (PIRS) operates in the Research and Development in Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.